Marshall Morningstar

Marshall Morningstar is a highly experienced pharmaceutical professional currently serving as Senior Director at Corbus Pharmaceuticals since July 2021, where responsibilities include directing chemistry efforts and managing CMC and drug product for small molecule programs related to the endocannabinoid system. As Principal at Morningstar Consulting since June 2017, Marshall has directed chemistry initiatives for multiple organizations while contributing to patent filings and developing medicinal chemistry strategies. Earlier experience includes Director of Medicinal Chemistry at Broad Institute, where Marshall successfully advanced drug candidates, and roles at GVK Biosciences, AstraZeneca, and Tanabe Seiyaku, focusing on early discovery and competitive intelligence. Marshall holds a Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology and completed postdoctoral research at the National Cancer Institute.